Document:

Exhibit 10.1

 

Sonus Networks, Inc.

4 Technology Park Drive

Westford, MA 01886

 

December 26, 2014

 

[NAME of Executive]

By electronic delivery

 

Dear [NAME of Executive]:

 

Based on your desire to demonstrate your support for Sonus Networks, Inc. (the “Company”) and its prospects, the Compensation Committee has considered and will agree to your request to forgo the payment of all or half of your cash bonus for 2015 and, if any such bonus would have been earned, to instead accept a grant of shares of the Company’s common stock.

 

You have elected to receive all or half (please indicate below and initial your election) of your fiscal year 2015 bonus (“2015 Bonus”), if any is earned, in the form of shares of the Company’s common stock (“2015 Bonus Shares”), which will be granted and have the terms described below:

 

	
o 100% stock
    	
o 50% stock and 50% cash
    	
Initials:
    

 

a.              If you elect to receive your 2015 Bonus entirely in the form of shares of common stock, the number of 2015 Bonus Shares granted will equal 1.5 times your actual 2015 Bonus earned, which bonus shall be determined by the Compensation Committee in its sole discretion subject to the terms of the 2015 bonus program, divided by the closing price of the Company’s shares on January 2, 2015.  If you elect to receive one-half your 2015 Bonus in the form of shares of common stock and the other half in the form of cash, (i) the number of 2015 Bonus Shares granted will be one-half the amount described in the preceding sentence; and (ii) you will receive 50% of your 2015 Bonus in cash on a date concurrent with the timing of normal 2015 bonus payouts.

 

b.              The 2015 Bonus Shares will be granted and vest in full on the grant date, which shall be concurrent with the timing of normal 2015 bonus payouts.  The Company will offset the number of shares necessary to pay withholding taxes and deposit the balance of the 2015 Bonus Shares in your account.

 

c.               You hereby agree not to sell or otherwise dispose of the 2015 Bonus Shares until the first anniversary of the date of grant.  Such contractual holding period may be waived by the Compensation Committee in its sole discretion, upon your death or disability or upon a showing of undue hardship.

 

You must remain an employee of the Company on the grant date in order to receive the 2015 Bonus Shares (if earned).  The parties hereby acknowledge that the Compensation Committee retains the right, in its sole discretion, to pay your 2015 Bonus in cash as opposed to payment in 2015 Bonus Shares; provided that, if the Company is the subject of an acquisition or change of control prior to the grant date and if the Compensation Committee of the Company (or its successor) elects to pay the 2015 Bonus, if any, in cash, such cash payment will equal the economic equivalent of the 2015 Bonus Shares that otherwise would have been received, so that the intent of this election is preserved.

 

Very truly yours,

 

 

	
 
    	
 
    	
 
    
	
[John   Schofield
    	
 
    	
 
    
	
Chair,   Compensation Committee
    	
 
    	
 
    
	
/Raymond   P. Dolan, President
    	
 
    	
 
    
	
and   Chief Executive Officer]
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
ACCEPTED:
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
[Name   of Executive]
    	
 
    	
Date:EX-10.1

 Exhibit 10.1 

PERFORMANCE SHARE AWARD WAIVER AGREEMENT 

THIS PERFORMANCE SHARE AWARD WAIVER AGREEMENT (the “Agreement”) is entered into as of December 24, 2014, by and between
Safeway Inc., a Delaware corporation (the “Company”), and Kelly P. Griffith (the “Executive”). 
 WHEREAS,
it is anticipated that a wholly-owned subsidiary of Albertson’s Holdings LLC, a Delaware limited liability company (“Parent”) shall merge (the “Merger”) with and into the Company pursuant to an Agreement and
Plan of Merger dated March 6, 2014 (the “Merger Agreement”), by and among the Company, AB Acquisition LLC, a Delaware limited liability company (“Ultimate Parent”), Parent, Albertsons LLC, a Delaware limited
liability company and wholly owned subsidiary of Parent (“Albertson’s LLC”) and Saturn Acquisition Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Parent (“Merger Sub” and, together with
Ultimate Parent, Parent and Albertson’s LLC, “Albertsons”); 
 WHEREAS, the Executive entered into a Performance Share
Award Grant Notice and Agreement with the Company dated March 8, 2013 (the “Award Agreement”); 
 WHEREAS, pursuant to
the terms of the Merger Agreement and the Award Agreement, the Executive may become entitled to the vesting of certain Performance Shares in connection with the Merger; 

WHEREAS, the vesting of the Performance Shares in connection with the Merger could constitute “parachute payments” made in
connection with a “change in control” of a corporation, within the meaning of Section 280G of the Internal Revenue Code of 1986, as amended (the “Code”) and the regulations issued thereunder, which could result in the
imposition of certain excise taxes on the Executive under Section 4999 of the Code and in the loss of certain income tax deductions by the Company or its successors or affiliates under Section 280G of the Code if any such “parachute
payments” constitute “excess parachute payments,” within the meaning of Section 280G of the Code; 
 WHEREAS, the
parties to this Agreement have determined that it is in their respective best interests to enter into an agreement which limits the vesting of certain of the Performance Shares under the Award Agreement and waives the rights of the Executive to
receive shares or consideration in the Merger with respect to such waived Performance Shares so as to avoid having any “excess parachute payments” under Section 280G of the Code become payable to the Executive at the time of closing
of the Merger; and 
 WHEREAS, each of the Executive and the Company now desires to enter into this Agreement. 

NOW, THEREFORE, the parties agree as follows: 

SECTION 1. 
 WAIVER
BY EXECUTIVE 
 Notwithstanding anything contained to the contrary in the Award Agreement or the Merger Agreement, effective immediately
prior to the closing of the Merger, the Executive 

 
hereby forfeits, and irrevocably waives his right to receive any consideration in connection with the Merger with respect to, 4,000 of the Performance Shares awarded to him pursuant to the Award
Agreement. 
 SECTION 2. 

RETENTION BONUS 
 Provided
the Executive remains continuously employed by the Company or Albertsons, or one of their affiliates, from the date hereof through January 2, 2016, the Company shall pay to Executive a one-time retention bonus in an amount equal to $130,000
(the “Retention Bonus”). The Retention Bonus will be paid on the first regular payroll date following January 2, 2016, subject to all applicable withholding. 

If the Executive’s employment with the Company terminates on or prior to January 2, 2016, other than due to a termination of his
employment without Cause (as defined in the Award Agreement) or his resignation for Good Reason (as defined in the Award Agreement), the Executive shall immediately forfeit any right to receive the Retention Bonus and shall have no further rights
with respect thereto. Notwithstanding any of the forgoing, if the Executive’s employment is terminated without Cause or he resigns for Good Reason on or prior to January 2, 2016, the Executive shall be entitled to receive the
Retention Bonus payable as a cash lump sum as soon as practicable after the date of such termination of employment (and in no event later than 30 days after the date of such termination of employment). 

* * * * * 
 This Agreement shall
be governed by and construed under the internal laws of the State of Delaware and may be executed in several counterparts (all of which together shall constitute one and the same instrument). The Executive acknowledges and agrees that the Executive
has carefully read this Agreement in its entirety; fully understands and agrees that the Executive is irrevocably waiving the Executive’s right to receive certain payments and benefits pursuant to Section 1; and intends and agrees that
this Agreement be final and legally binding on the Executive and the Company. 
  

			
	SAFEWAY INC.	    	EXECUTIVE
		
	 /s/ Laura Donald
	    	 /s/ Kelly P. Griffith

	By: Laura Donald	    	Kelly P. Griffith
	Its: Vice President, Corporate Law	    	
	Date: 12/24/14	    	Date: 12/24/14

  
 2 

 Acknowledged and Agreed: 
  

			
	AB MANAGEMENT SERVICES CORP.	    	
		
	 /s/ Paul G. Rowan
	    	
	By: Paul G. Rowan	    	
	Its: EVP & GC	    	
	Date: 12/24/14	    	

  
 3Exhibit 10.31

ASSIGNMENT OF INVENTION AND
PATENT APPLICATION

Whereas I, Christine Ichim,
a citizen of the Canada residing in Spring Valley, CA herein referred to as ASSIGNOR, have invented new and useful innovations
described in “TREATMENT OF MYELODYSPLASTIC SYNDROME BY INHIBITION OF NR2F6”, the specification of which was filed on
December 16, 2014 as U.S. Non-Provisional Patent Application No 14/572,574, herein referred to as the Invention

And Whereas, Regen BioPharma,
Inc., with its principal place of business at 4700 Spring St., Suite 304, La Mesa, CA 91942 herein referred to as ASSIGNEE, desires
to acquire the entire right, title, and interest in and to the said Invention,

Now therefore, for good and
valuable consideration, the receipt and sufficiency of which is hereby acknowledged, ASSIGNOR hereby acknowledges that they have
sold, assigned, transferred, and set over, and by these presents do hereby sell, assign, and transfer, and set over unto ASSIGNEE
and its successors and assigns, 100% of the following:

(A) ASSIGNOR’S right,
title and interest in and to the Invention entitled in“TREATMENT OF MYELODYSPLASTIC SYNDROME BY INHIBITION OF NR2F6”,
US Non- Provisional Patent Application No. 14/572,574 filed December 15, 2014,

(B) any patent or reissues that
claim priority to U.S. Non-Provisional Application No 14/572,574; and  

(C) any continuations, continuations-in-part,
substitutes, or divisionals that claim priority to US Non-Provisional Application No. 14/572,574.

ASSIGNOR authorizes and requests
the Commissioner for Patents to issue any resulting patent(s) as follows: 0% to ASSIGNOR and 100% to ASSIGNEE.

ASSIGNOR hereby further sells,
assigns, transfers and sets over unto ASSIGNEE, 100% of ASSIGNOR’S entire right, title, and interest in and to said invention
in the United States and every country foreign to the United States. ASSIGNOR agrees to execute all papers, give any required testimony,
and perform other lawful acts, at ASSIGNEE’S expense, as ASSIGNEE may require to enable ASSIGNEE to perfect ASSIGNEE’S
interest in any resulting patent of the United States and countries foreign thereto, and to acquire, hold, enforce, convey, and
uphold the validity of said patent and reissues and extensions thereof, and ASSIGNEE’S interest therein.

In testimony whereof ASSIGNOR
intending to be legally bound hereunto affix his signature.

ASSIGNOR

	/s/ Christine Ichim	December 17, 2014
	(Christine Ichim)	(Date)

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00238-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00238-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00238-of-00352.parquet"}]]